Related Experiment Videos
Pleural mesothelial cell (PMC) defense mechanisms against malignancy
Najmunnisa Nasreen1, Kamal A Mohammed, Kerry Sanders
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Veterans Affairs Medical Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Oncology Research
|February 6, 2004
Summary
Pleural mesothelial cells release the antiangiogenic factor endostatin, which helps prevent tumor spread. This study found endostatin levels were higher in non-cancerous pleural fluids and decreased when cancer cells directly contacted mesothelial cells.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Tumors frequently metastasize to the pleura, involving ovarian, lung, and breast cancers.
- Pleural mesothelial cells (PMCs) are implicated in pleural inflammation through cytokine release.
- The defense mechanisms of PMCs against malignant cell invasion remain largely unknown.
Purpose of the Study:
- To investigate the role of PMCs in inhibiting malignant cell invasion.
- To test the hypothesis that PMCs release endostatin, an antiangiogenic factor, to prevent tumor spread.
- To evaluate endostatin levels in malignant and non-malignant pleural effusions.
Main Methods:
- Quantification of endostatin levels in malignant (MAL) and congestive heart failure (CHF) pleural fluids (PF).
- Assessment of endostatin expression in PMCs using Western analysis and confocal microscopy.
- Co-culture experiments involving PMCs and ovarian cancer cells (OCCs) to study endostatin production under varying conditions.
Main Results:
- CHF PF exhibited significantly higher endostatin levels compared to MAL PF.
- PMCs produced significantly more endostatin than OCCs when cultured alone.
- Endostatin production by PMCs increased when co-cultured with OCCs without direct contact, but decreased upon direct contact.
- Endostatin production was upregulated by the presence of tumor cells, but not by adherent OCCs on a PMC monolayer.
Conclusions:
- PMCs are key producers of endostatin in the pleural space, contributing to antiangiogenesis.
- Endostatin release by PMCs plays a crucial role in preventing tumor metastasis within the pleura.
- The interaction between PMCs and tumor cells influences endostatin production, suggesting a dynamic defense mechanism.